The analgesic effects of Oxytocin

The analgesic effects of Oxytocin in women undergoing cesarean section under spinal anesthesia

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190905044705N1

Enrollment

Registered

2021-12-23

Start date

2021-12-06

Completion date

Unknown

Last updated

2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean.

Interventions

Intervention 1: Intervention group: Patients referred for cesarean section. For spinal anesthesia of 0.5% bupivacaine hydrochloride (4 ml / 20 mg ampoule - Mylan made in France by Haupt Pharma Livron

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All patients referred for cesarean section Lack of exclusion criteria

Exclusion criteria

Exclusion criteria: History of chronic pain and analgesic use, bleeding or coagulation disorder, peptic ulcer, renal or hepatic insufficiency and asthma, uterine atony, twins, placenta previa, Placental abruption, accreta placenta

Design outcomes

Primary

Measure	Time frame
Pain after cesarean section. Timepoint: Up to 24 hours after delivery. Method of measurement: Verbal Rating Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Mahdi Mir Nasseri

Qazvin University of Medical Sciences

mirnasseri@gmail.com44321888

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026